"NIH-funded scientists are perennially expected to do more with less," writes one stakeholder. Another observer writes, "The ...

Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

February 19, 2025 expert reaction to the announcement of the expansion of the OpenSAFELY data platform . Scientists comment on the expansion of the OpenSAFELY data platform. Prof ...

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Rajneesh Patil, vice president, digital innovation, IQVIA ...

As AI continues its integration into healthcare, the conversation has shifted from potential to practical impact.

Scientists across Africa, America, Asia, Australia, and Europe outline for the first time how Artificial Intelligence (AI) can transform the landscape of infectious disease research and improve ...

Five years ago a BMJ investigation found that medical students were being let down by poor monitoring and responses to ...

Understanding biosimilars, biologics, and the challenges surrounding their regulation and pricing in the pharmaceutical ...

NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision medical education." ...